DI
DIK.F Denka Company Limited
- Market cap
- EUR 1.40B
- P/E
- 13.7x
- P/B
- 0.78x
- ROE
- 5.1%
- Dividend yield
- 3.50%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Mar 2026.
Is DIK.F undervalued?
Graham numberDIK.F trades 31.1% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Denka Company Limited fundamental analysis
No fundamental analysis for Denka Company Limited yet.
Denka Company Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Denka Company Limited
Denka Company Limited manufactures and sells organic and inorganic, electronic material, pharmaceutical, and resin-related products in Japan, Asia, and internationally. It operates through Electronic and Advanced Products; Life Innovation; Elastomer Infrastructure Solutions; Polymer Solutions; and Other Business segments. The Electronic and Advanced Products segment manufactures and sells fused silica, spherical alumina, electronic circuit boards, fine ceramics, electronic p…
Full company profileDenka Company Limited financial statements
Denka Company Limited annual financial statements (JPY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 363B | 396B | 413B | 381B | 354B | 385B | 408B | 389B | 400B | 384B |
| Gross Profit | 89.4B | 100B | 102B | 99.3B | 100B | 107B | 102B | 82.5B | 84.6B | 94.3B |
| Operating Income | 25.8B | 33.7B | 34.2B | 31.6B | 34.7B | 40.1B | 32.3B | 13.4B | 14.4B | 26.2B |
| EBITDA | - | 54.9B | 56.1B | 52.4B | 52.8B | 59.4B | 42.8B | 43.1B | 12.9B | 52.6B |
| Net Income | 18.1B | 23.0B | 25.0B | 22.7B | 22.8B | 26.0B | 12.8B | 11.9B | -12.3B | 15.7B |
| EPS | 205 | 263 | 288 | 263 | 264 | 302 | 148 | 139 | -143 | 182 |
| Balance Sheet | ||||||||||
| Total Assets | 455B | 475B | 484B | 501B | 526B | 558B | 592B | 616B | 656B | 681B |
| Total Liabilities | 227B | 232B | 233B | 247B | 256B | 266B | 292B | 299B | 347B | 342B |
| Shareholders' Equity | 224B | 239B | 247B | 251B | 267B | 288B | 296B | 308B | 296B | 311B |
| Cash & Short-term Investments | 10.3B | 14.1B | 13.9B | 29.2B | 25.9B | 20.2B | 20.2B | 35.4B | 37.0B | 35.3B |
| Cash Flow | ||||||||||
| Operating Cash Flow | 39.6B | 48.8B | 32.7B | 42.0B | 40.6B | 42.6B | 8.95B | 36.3B | 18.6B | 36.2B |
| Capital Expenditure | 22.0B | 25.0B | 27.3B | 33.1B | 36.8B | 37.4B | 39.8B | 44.7B | 59.8B | 67.6B |
| Free Cash Flow | - | 23.4B | 5.20B | 8.12B | 3.12B | 4.68B | -30.9B | -8.42B | -41.2B | -31.5B |
| Ratios | ||||||||||
| ROE | 8.1% | 9.6% | 10.1% | 9.1% | 8.5% | 9.0% | 4.3% | 3.9% | -4.2% | 5.1% |
| ROA | 4.0% | 4.8% | 5.2% | 4.5% | 4.3% | 4.7% | 2.2% | 1.9% | -1.9% | 2.3% |
| Net Profit Margin | 5.0% | 5.8% | 6.1% | 6.0% | 6.4% | 6.8% | 3.1% | 3.1% | -3.1% | 4.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Denka Company Limited dividends
- Dividend yield
- 3.50%
- Forward dividend
- 0.56 EUR
- Payout ratio
- 55.0%
- Ex-dividend date
- Mar 30, 2027
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | JPY 8.63B | 100 | 55.0% |
| 2025 | JPY 7.76B | 90 | - |
| 2024 | JPY 7.76B | 90 | 65.0% |
| 2023 | JPY 12.5B | 145 | 98.0% |
| 2022 | JPY 11.6B | 135 | 44.8% |
| 2021 | JPY 10.8B | 125 | 47.3% |
| 2020 | EUR 10.4B | 121 | 45.8% |
| 2019 | EUR 10.1B | 116 | 40.3% |
| 2018 | EUR 7.48B | 85 | 32.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:5 on Sep 27, 2017.
Who owns Denka Company Limited
- Insiders 3.44%
- Institutions 53.76%
- Public & others 42.80%
- Shares outstanding 86.2M
- Free float 83.4M
Denka Company Limited company profile
- Company name
- Denka Company Limited
- Ticker
- DIK.F
- ISIN
- JP3549600009
- Exchange
- Frankfurt Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 6,454
- Fiscal year end
- March
- Address
- Nihonbashi Mitsui Tower, Chuo, Japan, 103-8338
- Phone
- 81 3 5290 5055
- Website
- denka.co.jp
About Denka Company Limited
Denka Company Limited manufactures and sells organic and inorganic, electronic material, pharmaceutical, and resin-related products in Japan, Asia, and internationally. It operates through Electronic and Advanced Products; Life Innovation; Elastomer Infrastructure Solutions; Polymer Solutions; and Other Business segments. The Electronic and Advanced Products segment manufactures and sells fused silica, spherical alumina, electronic circuit boards, fine ceramics, electronic packaging materials, acetylene These include carbon black, electrical construction materials, adhesive tapes, and semiconductor processing materials. Its Life Innovation segment offers vaccines, antigen rapid diagnostic kits, clinical reagents, and cancer treatment virus preparations, as well as develops, manufactures, and sells clinical reagents. The Elastomer infrastructure solutions segment provides chloroprene rubber, fertilizer, carbide, refractories, special additives, and polyethylene corrugated pipes, as well as manufactures and sells fused phosphate fertilizer and fused silica phosphate fertilizer and special admixtures. Its Polymer Solutions segment offers styrene monomers, ABS resin, SBC resin, N-phenylmaleimide resin, transparent resin, polyvinyl chloride, These include burrs, synthetic fibers for wigs and hairpieces, and sheets for food packaging, as well as manufactures and sells acetic acid and other related products, and synthetic fibers for wigs and hairpieces. The Other Business segment engages in plant engineering and wholesaling businesses. The company was formerly known as Denki Kagaku Kogyo Kabushiki Kaisha and changed its name to Denka Company Limited in October 2015. Denka Company Limited was incorporated in 1915 and is headquartered in Chuo, Japan.
Denka Company Limited management
10- Mr. Ikuo IshidaPresident, CEO & Representative Director · born 1962
- Mr. Rimiru HayashidaCSCO, CFO and SMEO of Acco, Finance, Pur., Logi. & Corporate Comm. Dept. & Director · born 1961
- Mr. Masanobu KosakaManaging Executive Officer, CTO & Director · born 1963
- Mr. Akinori AdachiExecutive Officer of Administrative Dept., Legal Dept., Internal Control Dept. & Secretary Dept.
- Mr. Kei HaraManaging Executive Officer and Chief Human Resource & Compliance Officer · born 1967
- Hiroyuki YamamotoGeneral Manager of Corporate Communications Department
- Mr. Hiroto HoriuchiManaging Executive Officer · born 1967
- Mr. Masahide YamadaExecutive Officer & Head of New Business Development.
- Masahiro KawaiExecutive Officer & MD of DCHA, DSPL, DAPL
- Mr. Taro InadaExecutive Officer, GM & Head of Life Innovation